NCT01527292

Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

Randomized Phase II Trial of Stereotactic Radiation Therapy (SRT) Versus SRT Plus Vertebral Augmentation Procedure (VAP) for Vertebral Metastasis

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 3 (actual)
• Sponsor: University of Louisville · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine pain control rate (Percentage of patients in each arm that achieve pain control) at the treated site(s) at 1 month, 2-4 months and 5-6 months post-treatment.

Detailed description

Eligible Vertebral Metastatic Lesion/s-\> randomized-\> SRT versus SRT+ VAP Stereotactic Radiation Therapy(SRT): 16 Gy X 1 Evaluation: prior to treatment; 1 month, 2-4 months, 5-6 months and 1 year post-treatment

Conditions

• Vertebral Metastasis

Interventions

Type	Name	Description
RADIATION	Stereotactic Radiation Therapy	SRT only
RADIATION	SRT with Vertebral Augmentation Procedure	SRT with VAP

Timeline

• Start date: 2012-02-01
• Primary completion: 2015-05-02
• Completion: 2015-09-02
• First posted: 2012-02-07
• Last updated: 2019-02-05
• Results posted: 2019-02-05

Locations

1 site across 1 country: United States